| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Circulating Tumour DNA for Detecting Minimal Residual Disease in Multiple Myeloma
|
Pugh, Trevor J.
|
|
2018
|
55 |
1 |
p. 38-40
|
artikel
|
| 2 |
Comprehensive characterization of circulating and bone marrow-derived multiple myeloma cells at minimal residual disease
|
Waldschmidt, Johannes M.
|
|
2018
|
55 |
1 |
p. 33-37
|
artikel
|
| 3 |
Functional Imaging Methods for Assessment of Minimal Residual Disease in Multiple Myeloma: Current Status and Novel ImmunoPET Based Methods
|
Pandit-Taskar, Neeta
|
|
2018
|
55 |
1 |
p. 22-32
|
artikel
|
| 4 |
Mass spectrometry methods for detecting monoclonal immunoglobulins in multiple myeloma minimal residual disease
|
Thoren, Katie L.
|
|
2018
|
55 |
1 |
p. 41-43
|
artikel
|
| 5 |
Masthead
|
|
|
2018
|
55 |
1 |
p. IFC
|
artikel
|
| 6 |
Minimal Residual Disease Detection by Flow Cytometry in Multiple Myeloma: Why and How?
|
Roshal, Mikhail
|
|
2018
|
55 |
1 |
p. 4-12
|
artikel
|
| 7 |
Minimal residual disease detection of myeloma using sequencing of immunoglobulin heavy chain gene VDJ regions
|
Ho, Caleb
|
|
2018
|
55 |
1 |
p. 13-18
|
artikel
|
| 8 |
Minimal residual disease in multiple myeloma: use of magnetic resonance imaging
|
Hillengass, Jens
|
|
2018
|
55 |
1 |
p. 19-21
|
artikel
|
| 9 |
MRD Testing in Multiple Myeloma: From a Surrogate Marker of Clinical Outcomes to an Every-Day Clinical Tool
|
Landgren, Ola
|
|
2018
|
55 |
1 |
p. 1-3
|
artikel
|
| 10 |
MRD Testing in Multiple Myeloma: The Main Future Driver for Modern Tailored Treatment
|
Landgren, Ola
|
|
2018
|
55 |
1 |
p. 44-50
|
artikel
|
| 11 |
outside front cover, PMS 8883 metallic AND 4/C
|
|
|
2018
|
55 |
1 |
p. OFC
|
artikel
|
| 12 |
Table of Contents
|
|
|
2018
|
55 |
1 |
p. A1
|
artikel
|
Tijdschrift beschrijving